STK38L
| Official symbol: | STK38L |
| Full name: | serine/threonine kinase 38 like |
| Location: | 12p11.23 |
| Also known as: | NDR2, KIAA0965 |
| Entrez ID: | 23012 |
| Ensembl ID: | ENSG00000211455 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.57 | | Gscore (Del): | 0.00 |
|
|
| Recurrently amplified in 1 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 3 |
|
|
| Fusions detected in 3 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 15.46 (Percentile rank: 43.23%) |
| PubTator score: | 8.31 (Percentile rank: 36.64%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
